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A B S T R A C T
The German Stem Cell Network (GSCN) aims at creating synergies between all areas of basic and applied stem cell research and to provide an interface between
science, education, politics and society as a whole. The central task of the GSCN is to pool the expertise in stem cell research in Germany and develop synergies
between basic research, regenerative medicine and pharmacology. The initiative promotes innovative research activities on a national and international level. In
addition, targeted information and events are offered to encourage the public discourse on stem cell research. The objectives of the network are:
• To maintain an organizational structure for a German network for basic and applied stem cell research;• To organize joint annual conferences on stem cell research to be rotated among German cities;• To coordinate scientific and strategic working groups;• To provide a platform for communication on stem cell research, enabling exchange of important news, discussions and networking between scientists, institu-
tions, policy-makers and the general public (in German and English);• To publish documents about basic and applied stem cell research in Germany and help to organize public meetings and outreach programs on these topics.
1. The mission of the GSCN
The German Stem Cell Network (GSCN) is a nationwide network of
and for stem cell researchers (Saini, 2013). The goal of the GSCN is to
create synergies between all areas of basic and applied stem cell re-
search and to form an interface between science, education, politics and
society. The network has made it its central task to bundle the existing
competences in the field of stem cell research in Germany and to de-
velop synergies with the fields of regenerative medicine in order to
bring about new national and international research activities and
collaborations (GSCN, 2013d). In addition, public relations measures
provide target group-specific information and education on this im-
portant field of research.
The GSCN defines itself as a hub for contacts and as a platform for
the rapprochement of different fields around the dynamically devel-
oping and relatively young cross-sectional technology of stem cell re-
search. In such a diverse and interdisciplinary field, it is important to
create an opportunity for the exchange of knowledge, data, protocols
and know-how to a mutual benefit. A scientific network is dynamic and
successful if it is supported, enriched and driven from a center of
content and logistics.
In addition to scientific exchange, a task of the GSCN is to provide
decision-makers with decisive information - thus representing the in-
terests of stem cell researchers as a group in discussions with politicians
and initiating national decision-making processes. Stem cell research
and regenerative medicine are promising prospects for a large group of
patients whose diseases have not yet been cured or treated. The GSCN is
particularly committed to providing this target group with scientifically
based information on the current state of applied stem cell research.
This includes the communication of progress and success in clinical
trials as well as warnings against unproven, dubious therapies. Stem
cell biology is a relatively young field that is growing dynamically and
evolving in many areas of basic research, applied research, drug testing
and organoid research. In the field of public relations, the GSCN has set
itself the goal to inform students in schools about stem cell biology in
order to bring their knowledge up to date.
2. A brief history of the GSCN
The German Federal Ministry of Education and Research (BMBF)
gave the go-ahead for the establishment of a platform for stem cell
research in Germany in 2009. The goal was to establish a scientific
network for the evolving field of stem cell research. The call was fol-
lowed by several application phases and further discussions until 2013,
when a committee consisting of 13 renowned scientists founded the
GSCN. This process succeeded in integrating large parts of the national
stem cell community into the GSCN and simultaneously building a
bridge to the field of regenerative medicine. The establishment of the
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GSCN was preceded by a national dialogue with German stem cell re-
searchers on the contents and objectives of the network at a kick-off
meeting of the founding committee in Frankfurt (20 March 2013) as
well as comprehensive online surveys. The online survey (15 April - 30
June 2013) was completed by 148 scientists, 13 institutes and 20
companies. It concluded that the desired version of the network was a
bottom-up approach that focused on young scientists and the pre-
sentation of their data at annual conferences, in addition to providing
the scientific community with the necessary platform for exchange and
networking. Research group leaders are important initiators in the de-
cision-making bodies of the GSCN and are available at the GSCN Annual
Conferences as session chairs and discussion partners.
3. Governance and finances
The GSCN is an association with more than 400 members, including
19 research institutes and 15 companies (GSCN, 2013a). A central office
with a managing director, a project manager and a communications
coordinator is located at the Max Delbrück Center for Molecular Med-
icine (MDC) in Berlin (GSCN, 2013c). The governance structure of the
non-profit association GSCN is organized on three levels: The de-
termining organ of the society is the General Meeting of the members,
which assembles once a year at the GSCN Annual Conference, decides
on the affairs of the network, receives the financial report and exon-
erates the Executive Board. All board members are elected by the
members through annual online elections. The Executive Board consists
of five persons, an acting president, a senior president, a designated
president, a treasurer and an assessor. All incumbents are appointed to
the Executive Board for six years and the presidents rotate every two
years to the following position. The Executive Board is the legal re-
presentative of the GSCN and is assisted by the managing director and
the staff of the GSCN central office. The managing board is supported
by an Extended Board of 15 scientists who are elected for three years.
The Extended Board discusses and advises the Executive Board on im-
portant decisions. At their annual meeting, they jointly decide on the
future directives for the network (GSCN, 2013f).
The GSCN is financed by the Federal Ministry of Education and
Research (BMBF) via the VDI-Technology Center (VDI-TZ, Grant No.
13GW0012 and 13GW0066) from 2013 until 2017 and DLR Project
Management Agency(Grant No. 01EK1701) since 2018 as well as by the
membership fees and conference revenues. Third-party funds from
foundations and other sponsors are also raised for individual projects.
From 2020 on, the future funding by the Berlin Institute of Health (BIH)
has been secured.
4. Structures in the GSCN
The network is structurally organized into 14 working groups: seven
scientific groups (GSCN, 2013e):
• Pluripotency and re-programing• Somatic stem cells and development• Basic, translational, applied hematopoiesis• Stem cells in disease (cancer stem cells)• Stem cells in regenerative therapies• Stem cells in disease modeling and drug development• Computational stem cell biology
and seven strategic working groups:
• Funding programs and policies• Career development• Public engagement and outreach activities• Ethical, legal and social aspects (ELSA)• Patient information (stem cell therapies)• Clinical trials and regulatory affairs
• Technologies in stem cell research.
The working groups are reflected in the conference program, and
their initiators propose annual keynotes, sessions in their subject areas
and select the oral presentations from the submitted abstracts.
5. Scientific and strategic events
The scientific activities of the GSCN are mainly based on the GSCN
working groups, its members and cooperating professional societies.
The main event of the GSCN is the Annual Conference (GSCN, 2013b).
Since 2013, the GSCN has organized the central stem cell conference in
Germany rotating among different cities with the support of the GSCN
Acting President and her/his institute, often at the same location:
• 2013: Berlin (Max Delbrück Center for Molecular Medicine (MDC))• 2014: Heidelberg (German Cancer Research Center (DKFZ))• 2015: Frankfurt (Goethe University)• 2016: Hannover (Hannover Medical School (MHH))• 2017: Jena (Friedrich Schiller University and Leibniz Institute for
Aging Research - Fritz Lipmann Institute (FLI))• 2018: Heidelberg (German Cancer Research Center (DKFZ))• 2019: Berlin (Max Delbrück Center for Molecular Medicine (MDC))
The conferences have so far been attended by approximately 400
scientists each and consist of parallel sessions structured according to
the GSCN working groups. In addition to introductory and concluding
international keynotes, these three-day meetings serve mainly to pre-
sent new data from young scientists, and to network and establish new
contacts and collaborations. A central element is the "Presidential
Symposium": By invitation of the GSCN President there is an interna-
tional keynote speaker, followed by three presentations of the GSCN
prize winners in the categories GSCN Young Investigator Award, GSCN
Female Scientist Award and GSCN Best Publication of the Year Award.
Part of the conference is the annually growing industry exhibition,
where companies present their products and hold lectures in their own
sessions within the conference framework.
In addition to the conference, the GSCN initiates, organizes and finances
scientific and strategic workshops, which are led by members of the
working groups and/or in cooperation with other institutes such as the Paul
Ehrlich Institute (PEI) as the national authority for the approval of biolo-
gical products. The spectrum of topics ranges from mathematical modeling
and bioinformatics to grant writing workshops for young researchers. A
special annual workshop that takes place once or twice a year is the non-PI
meeting - a meeting of young scientists without group leaders. This enables
the researchers to support each other and exchange information on scien-
tific questions as well as discuss structural topics amongst their peers. The
GSCN presents itself at conferences of other professional societies or the-
matically relevant conferences (e.g. Gordon Conferences and ISSCR Annual
Meetings as well as International Symposia) with sessions, lectures and
booths and offers financial support and travel stipends for young scientists.
The GSCN has also supported the PluriCore network, since its foundation in
2015, an association of German core units on stem cell technologies for the
exchange of protocols, cells and scientific data, in terms of organization,
content and funding (GSCN, 2015). The PluriCore network is presented
separately in the article “Cores: laboratories organization for stem cell tech-
nology advancement“ in this journal.
6. Public affairs
In its function as the ambassador of stem cell science in Germany,
the GSCN seeks contact with decision-makers in science policy in-
stitutions and in the relevant committees of the federal parliament
(Bundestag) for the life sciences and funding policy. To strengthen its
position, the GSCN has written two white papers on current topics in
stem cell research (GSCN, 2016c). In 2016, the GSCN published "Public
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funding of stem cell research - Germany in an international comparison"
with a collection of new data on public funding in the USA, Sweden,
Great Britain, Japan and Germany. The GSCN concluded that there is a
relative decline in public funding for stem cell research in Germany,
while the other countries in the comparison, which also rank among the
world leaders in stem cell research, are increasing their funding in the
expectation that stem cell therapies will soon be marketable.
The second white paper "Translation - from stem cells to innovative
therapies. Analysis and Recommendations for the Clinical Translation
of Stem Cell Research in Germany", published in 2018, examined the
hurdles in the translation process in a SWOT analysis based on inter-
views with national and international scientists, and formulated re-
commendations for action for politicians. Both white papers were pre-
sented to members of the Bundestag at meetings and were aimed to
initiate discussion and action.
An important topic in the stem cell community are "unproven
therapies", i.e. stem cell-based therapies that have not been proven by
scientific studies. They are usually offered to patients who are incurable
by standard therapies or for whose condition there is no therapy at all.
The providers of these stem cell therapies promise a success rate with
these "all-rounders" cells for the most diverse diseases and hide their
lack of scientific efficacy – since it does not exist. The GSCN has pub-
lished articles on this topic and has written a brochure that is available
online and in print and informs patients about the current status of stem
cell therapies (Besser et al., 2018) (GSCN, 2016b).
Current topics of stem cell research as well as reports from the ac-
tivities of the GSCN are published once a year in the GSCN Annual
Magazines (GSCN, 2014). The central office publishes the bilingual
magazine with a conference report, an extensive editorial section and
an annual report on the network activities. It is published online and
sent in print to the scientific community, association members and
decision makers. In 2017, the GSCN was also involved in the prepara-
tion of the 8th Stem Cell Report for the year 2016/2017 of the Federal
Government (Deutscher Bundestag, 2019).
7. Public outreach
The current state of stem cell research is important for many sta-
keholder groups. Patients and their families hope for early therapies.
The scientifically interested public sees the dynamics and findings in
stem cell research which, together with developments in the neigh-
boring fields of regenerative medicine, reproductive medicine and gene
editing, can lead to socially relevant changes. Students at schools are
educated in life sciences and experience that current research is often
not yet reflected in the teaching content.
In 2016, the GSCN initiated the UniStem Day in Germany especially
for the target group of school students (GSCN, 2016a). This education
day for pupils on stem cell topics was founded in Italy in 2009 and since
then has increased its European reach - in March 2019 more than
33,000 young people took part in the UniStem Day all over Europe. In
Germany, the GSCN is responsible for dissemination, and institutes in
15 cities with well over 1000 pupils took part in 2019 with lectures,
workshops, laboratory units and games. The GSCN has also developed
German and English teaching material on stem cell research for tea-
chers and students in the form of a scientific conference. The material is
available as an Open Educational Resource (OER) on the internet in the
English language at www.understanding-stemcells.info (GSCN and
Schering Stiftung, 2018) and in German at www.stammzellen-
verstehen.de (GSCN and Schering Stiftung, 2017). The material can
be downloaded free of charge and edited according to need.
The GSCN offers free public events for all stakeholder groups several
times a year, with stem cell researchers on the podium who present
their research in laymen's terms and discuss their questions with the
audience. A special feature of the GSCN is that it produces short film
portraits of the researchers - these are used as an introduction during
the event and later distributed via social media channels.
8. Outlook and perspectives
Every year, the GSCN widens its range of activities with the aim of
expanding its communication platform for stem cell research within the
German research community. These levels of action will be further
differentiated and strengthened in the future.
A further goal of the scientific community, which the GSCN actively
supports, is the establishment of stem cell banks both with human and
animal pluripotent cells. Stem cell banks with human cells are discussed
elsewhere in this Stem Cell Research special issue. Besides the general
trend in medicine to establish human stem cell banks, archives of an-
imal pluripotent stem cells are extremely rare. However, they will be of
special importance in the future. These collections are a comprehensive
source of biodiversity and could be the foundation of saving rare and
critical endangered species. Such material can initiate an entire new
field in conservation strategies using pluripotent stem cells for the
generation of artificial gametes for in vitro fertilization approaches.
Moreover, such material allows to study the evolution derived special
traits on cellular level in different species without utilizing animals in
such research. Decoding special adaptations and mechanisms in the
animal kingdom may provide potentially new inside in disease related
mechanisms and novel treatment options. In Germany the Leibniz
Institute for Zoo and Wildlife Research (IZW) in Berlin started their
collection of non-domestic species material. Since 2014 the IZW co-
operates with the Max Delbrück Center for Molecular Medicine (MDC)
to utilize the archive for the generation of induced pluripotent stem
cells (iPSC). Currently the IZW Biobank contains iPSCs from seven
species including from primates such as bonobo, gorilla and orangutan
as well as southern and northern white rhinoceroses. Together with the
support of the GSCN it is planned to establish a nation-wide network of
biobanks specialized in animal material like germ cells, DNA and so-
matic cells.
A special aspect is the support of translation of research with human
stem cells, since it is potentially significant for an ageing society. A
continuous ethical reflection on scientific developments are of great
importance here, as it assesses the social significance of research, its
applications and its acceptance. A further topic is the European per-
spective on stem cell research, since EU policy has a regulatory influ-
ence on national legislation, e.g. drug regulations on ATMPs, and
should therefore be accompanied by information and policy. The GSCN
is actively taking part in these activities and discussions on a national as
well as international level.
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